Nationwide registry-based trial of risk-stratified cervical screening

In well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 2025-01, Vol.156 (2), p.379-388
Hauptverfasser: Arroyo Mühr, Laila Sara, Wang, Jiangrong, Hassan, Sadaf S, Yilmaz, Emel, Elfström, Miriam K, Dillner, Joakim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 388
container_issue 2
container_start_page 379
container_title International journal of cancer
container_volume 156
creator Arroyo Mühr, Laila Sara
Wang, Jiangrong
Hassan, Sadaf S
Yilmaz, Emel
Elfström, Miriam K
Dillner, Joakim
description In well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry identified the 28,689 women residents in Sweden who had either no previous cervical screening or a screening history indicating high risk. We invited these women by SMS and/or physical letter to order a free human papillomavirus (HPV) self-sampling kit. The Swedish national HPV reference laboratory performed extended HPV genotyping and referred high-risk HPV-positive women to their regional gynecologist. A total of 3691/28,689 (12.9%) women ordered a self-sampling kit and 10.0% (2853/28,689) returned a sample for testing. Participation among women who had never attended screening was low, albeit improved. Up to 22.5% of women in other high-risk groups attended. High-risk HPV types were detected in 8.3% of samples. High-risk HPV-positive women (238/2853) were referred without further triaging and severe cervical precancer or cancer (HSIL+) in histopathology were detected in 36/158 (23%) of biopsied women. Repeat invitations gave modest additional participation. Nationwide contacting of women with high risk for cervical cancer with personal invitations to order HPV self-sampling kits resulted in high yield of detected CIN2+. Further efforts to improve risk-stratified screening strategies should be directed to improving (i) the precision of the risk-stratification algorithm, (ii) the convenience for the women to participate and, (iii) ensuring that screen-positive women are followed-up.
doi_str_mv 10.1002/ijc.35142
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_880315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3093593267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-840a4e81e088622d36435026f83713bdf2d04d6803c210dc93e08b91c38e00c3</originalsourceid><addsrcrecordid>eNpdkUtPwzAQhC0EgvI48AdQJS5wCKy9TuKcEEK8JAQX7lbqbIpLmoCdFvHv2dJSASdbns-j2R0hDiWcSQB17ifuDFOp1YYYSCjyBJRMN8WANUhyidmO2I1xAiBlCnpb7GAhdaZNMRDXj2Xvu_bDVzQMNPaxD5_JqIxUDfvgy2bY1cPg42vCApO1Z8FRmHvHWnSBqPXteF9s1WUT6WB17onnm-vnq7vk4en2_uryIXEaVJ8YDaUmIwmMyZSqMNOYgspqg5xyVNWqAl1lBtApCZUrkMlRIR0aAnC4J5Klbfygt9nIvgU_LcOn7UpvV0-vfCNr2EKmzF8seVamVDlqeYjmz7e_Sutf7LibW95TbiBfOJysHEL3PqPY26mPjpqmbKmbRYtQYFqgynJGj_-hk24WWl6HRYmQIaZmQZ0uKRe6GAPV6zQS7KJMy2Xa7zKZPfodf03-tIdf1cGaGA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3130633587</pqid></control><display><type>article</type><title>Nationwide registry-based trial of risk-stratified cervical screening</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>SWEPUB Freely available online</source><creator>Arroyo Mühr, Laila Sara ; Wang, Jiangrong ; Hassan, Sadaf S ; Yilmaz, Emel ; Elfström, Miriam K ; Dillner, Joakim</creator><creatorcontrib>Arroyo Mühr, Laila Sara ; Wang, Jiangrong ; Hassan, Sadaf S ; Yilmaz, Emel ; Elfström, Miriam K ; Dillner, Joakim</creatorcontrib><description>In well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry identified the 28,689 women residents in Sweden who had either no previous cervical screening or a screening history indicating high risk. We invited these women by SMS and/or physical letter to order a free human papillomavirus (HPV) self-sampling kit. The Swedish national HPV reference laboratory performed extended HPV genotyping and referred high-risk HPV-positive women to their regional gynecologist. A total of 3691/28,689 (12.9%) women ordered a self-sampling kit and 10.0% (2853/28,689) returned a sample for testing. Participation among women who had never attended screening was low, albeit improved. Up to 22.5% of women in other high-risk groups attended. High-risk HPV types were detected in 8.3% of samples. High-risk HPV-positive women (238/2853) were referred without further triaging and severe cervical precancer or cancer (HSIL+) in histopathology were detected in 36/158 (23%) of biopsied women. Repeat invitations gave modest additional participation. Nationwide contacting of women with high risk for cervical cancer with personal invitations to order HPV self-sampling kits resulted in high yield of detected CIN2+. Further efforts to improve risk-stratified screening strategies should be directed to improving (i) the precision of the risk-stratification algorithm, (ii) the convenience for the women to participate and, (iii) ensuring that screen-positive women are followed-up.</description><identifier>ISSN: 0020-7136</identifier><identifier>ISSN: 1097-0215</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.35142</identifier><identifier>PMID: 39146489</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Cancer ; Cervical cancer ; Early Detection of Cancer - methods ; Female ; Genotyping ; Human papillomavirus ; Humans ; Mass Screening - methods ; Medical screening ; Middle Aged ; Papillomaviridae - genetics ; Papillomaviridae - isolation &amp; purification ; Papillomavirus Infections - diagnosis ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - virology ; Population studies ; Registries ; RESEARCH ARTICLE ; Risk assessment ; Risk Assessment - methods ; Risk factors ; Risk groups ; Sampling ; Sweden - epidemiology ; Uterine Cervical Dysplasia - diagnosis ; Uterine Cervical Dysplasia - epidemiology ; Uterine Cervical Dysplasia - virology ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - virology ; Vaginal Smears - methods ; Women</subject><ispartof>International journal of cancer, 2025-01, Vol.156 (2), p.379-388</ispartof><rights>2024 The Author(s). International Journal of Cancer published by John Wiley &amp; Sons Ltd on behalf of UICC.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2024 The Author(s). published by John Wiley &amp; Sons Ltd on behalf of UICC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c402t-840a4e81e088622d36435026f83713bdf2d04d6803c210dc93e08b91c38e00c3</cites><orcidid>0000-0001-8588-6506 ; 0000-0003-2498-5206 ; 0000-0002-0514-7226 ; 0000-0002-0001-503X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39146489$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:159259850$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Arroyo Mühr, Laila Sara</creatorcontrib><creatorcontrib>Wang, Jiangrong</creatorcontrib><creatorcontrib>Hassan, Sadaf S</creatorcontrib><creatorcontrib>Yilmaz, Emel</creatorcontrib><creatorcontrib>Elfström, Miriam K</creatorcontrib><creatorcontrib>Dillner, Joakim</creatorcontrib><title>Nationwide registry-based trial of risk-stratified cervical screening</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>In well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry identified the 28,689 women residents in Sweden who had either no previous cervical screening or a screening history indicating high risk. We invited these women by SMS and/or physical letter to order a free human papillomavirus (HPV) self-sampling kit. The Swedish national HPV reference laboratory performed extended HPV genotyping and referred high-risk HPV-positive women to their regional gynecologist. A total of 3691/28,689 (12.9%) women ordered a self-sampling kit and 10.0% (2853/28,689) returned a sample for testing. Participation among women who had never attended screening was low, albeit improved. Up to 22.5% of women in other high-risk groups attended. High-risk HPV types were detected in 8.3% of samples. High-risk HPV-positive women (238/2853) were referred without further triaging and severe cervical precancer or cancer (HSIL+) in histopathology were detected in 36/158 (23%) of biopsied women. Repeat invitations gave modest additional participation. Nationwide contacting of women with high risk for cervical cancer with personal invitations to order HPV self-sampling kits resulted in high yield of detected CIN2+. Further efforts to improve risk-stratified screening strategies should be directed to improving (i) the precision of the risk-stratification algorithm, (ii) the convenience for the women to participate and, (iii) ensuring that screen-positive women are followed-up.</description><subject>Adult</subject><subject>Aged</subject><subject>Cancer</subject><subject>Cervical cancer</subject><subject>Early Detection of Cancer - methods</subject><subject>Female</subject><subject>Genotyping</subject><subject>Human papillomavirus</subject><subject>Humans</subject><subject>Mass Screening - methods</subject><subject>Medical screening</subject><subject>Middle Aged</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - isolation &amp; purification</subject><subject>Papillomavirus Infections - diagnosis</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - virology</subject><subject>Population studies</subject><subject>Registries</subject><subject>RESEARCH ARTICLE</subject><subject>Risk assessment</subject><subject>Risk Assessment - methods</subject><subject>Risk factors</subject><subject>Risk groups</subject><subject>Sampling</subject><subject>Sweden - epidemiology</subject><subject>Uterine Cervical Dysplasia - diagnosis</subject><subject>Uterine Cervical Dysplasia - epidemiology</subject><subject>Uterine Cervical Dysplasia - virology</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - virology</subject><subject>Vaginal Smears - methods</subject><subject>Women</subject><issn>0020-7136</issn><issn>1097-0215</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNpdkUtPwzAQhC0EgvI48AdQJS5wCKy9TuKcEEK8JAQX7lbqbIpLmoCdFvHv2dJSASdbns-j2R0hDiWcSQB17ifuDFOp1YYYSCjyBJRMN8WANUhyidmO2I1xAiBlCnpb7GAhdaZNMRDXj2Xvu_bDVzQMNPaxD5_JqIxUDfvgy2bY1cPg42vCApO1Z8FRmHvHWnSBqPXteF9s1WUT6WB17onnm-vnq7vk4en2_uryIXEaVJ8YDaUmIwmMyZSqMNOYgspqg5xyVNWqAl1lBtApCZUrkMlRIR0aAnC4J5Klbfygt9nIvgU_LcOn7UpvV0-vfCNr2EKmzF8seVamVDlqeYjmz7e_Sutf7LibW95TbiBfOJysHEL3PqPY26mPjpqmbKmbRYtQYFqgynJGj_-hk24WWl6HRYmQIaZmQZ0uKRe6GAPV6zQS7KJMy2Xa7zKZPfodf03-tIdf1cGaGA</recordid><startdate>20250115</startdate><enddate>20250115</enddate><creator>Arroyo Mühr, Laila Sara</creator><creator>Wang, Jiangrong</creator><creator>Hassan, Sadaf S</creator><creator>Yilmaz, Emel</creator><creator>Elfström, Miriam K</creator><creator>Dillner, Joakim</creator><general>Wiley Subscription Services, Inc</general><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope><orcidid>https://orcid.org/0000-0001-8588-6506</orcidid><orcidid>https://orcid.org/0000-0003-2498-5206</orcidid><orcidid>https://orcid.org/0000-0002-0514-7226</orcidid><orcidid>https://orcid.org/0000-0002-0001-503X</orcidid></search><sort><creationdate>20250115</creationdate><title>Nationwide registry-based trial of risk-stratified cervical screening</title><author>Arroyo Mühr, Laila Sara ; Wang, Jiangrong ; Hassan, Sadaf S ; Yilmaz, Emel ; Elfström, Miriam K ; Dillner, Joakim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-840a4e81e088622d36435026f83713bdf2d04d6803c210dc93e08b91c38e00c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cancer</topic><topic>Cervical cancer</topic><topic>Early Detection of Cancer - methods</topic><topic>Female</topic><topic>Genotyping</topic><topic>Human papillomavirus</topic><topic>Humans</topic><topic>Mass Screening - methods</topic><topic>Medical screening</topic><topic>Middle Aged</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - isolation &amp; purification</topic><topic>Papillomavirus Infections - diagnosis</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - virology</topic><topic>Population studies</topic><topic>Registries</topic><topic>RESEARCH ARTICLE</topic><topic>Risk assessment</topic><topic>Risk Assessment - methods</topic><topic>Risk factors</topic><topic>Risk groups</topic><topic>Sampling</topic><topic>Sweden - epidemiology</topic><topic>Uterine Cervical Dysplasia - diagnosis</topic><topic>Uterine Cervical Dysplasia - epidemiology</topic><topic>Uterine Cervical Dysplasia - virology</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - virology</topic><topic>Vaginal Smears - methods</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arroyo Mühr, Laila Sara</creatorcontrib><creatorcontrib>Wang, Jiangrong</creatorcontrib><creatorcontrib>Hassan, Sadaf S</creatorcontrib><creatorcontrib>Yilmaz, Emel</creatorcontrib><creatorcontrib>Elfström, Miriam K</creatorcontrib><creatorcontrib>Dillner, Joakim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arroyo Mühr, Laila Sara</au><au>Wang, Jiangrong</au><au>Hassan, Sadaf S</au><au>Yilmaz, Emel</au><au>Elfström, Miriam K</au><au>Dillner, Joakim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nationwide registry-based trial of risk-stratified cervical screening</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2025-01-15</date><risdate>2025</risdate><volume>156</volume><issue>2</issue><spage>379</spage><epage>388</epage><pages>379-388</pages><issn>0020-7136</issn><issn>1097-0215</issn><eissn>1097-0215</eissn><abstract>In well-screened populations, most cervical cancers arise from small groups of women with inadequate screening. The present study aims to assess whether registry-based cancer risk assessment could be used to increase screening intensity among high-risk women. The National Cervical Screening Registry identified the 28,689 women residents in Sweden who had either no previous cervical screening or a screening history indicating high risk. We invited these women by SMS and/or physical letter to order a free human papillomavirus (HPV) self-sampling kit. The Swedish national HPV reference laboratory performed extended HPV genotyping and referred high-risk HPV-positive women to their regional gynecologist. A total of 3691/28,689 (12.9%) women ordered a self-sampling kit and 10.0% (2853/28,689) returned a sample for testing. Participation among women who had never attended screening was low, albeit improved. Up to 22.5% of women in other high-risk groups attended. High-risk HPV types were detected in 8.3% of samples. High-risk HPV-positive women (238/2853) were referred without further triaging and severe cervical precancer or cancer (HSIL+) in histopathology were detected in 36/158 (23%) of biopsied women. Repeat invitations gave modest additional participation. Nationwide contacting of women with high risk for cervical cancer with personal invitations to order HPV self-sampling kits resulted in high yield of detected CIN2+. Further efforts to improve risk-stratified screening strategies should be directed to improving (i) the precision of the risk-stratification algorithm, (ii) the convenience for the women to participate and, (iii) ensuring that screen-positive women are followed-up.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39146489</pmid><doi>10.1002/ijc.35142</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-8588-6506</orcidid><orcidid>https://orcid.org/0000-0003-2498-5206</orcidid><orcidid>https://orcid.org/0000-0002-0514-7226</orcidid><orcidid>https://orcid.org/0000-0002-0001-503X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2025-01, Vol.156 (2), p.379-388
issn 0020-7136
1097-0215
1097-0215
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_880315
source MEDLINE; Wiley Online Library Journals Frontfile Complete; SWEPUB Freely available online
subjects Adult
Aged
Cancer
Cervical cancer
Early Detection of Cancer - methods
Female
Genotyping
Human papillomavirus
Humans
Mass Screening - methods
Medical screening
Middle Aged
Papillomaviridae - genetics
Papillomaviridae - isolation & purification
Papillomavirus Infections - diagnosis
Papillomavirus Infections - epidemiology
Papillomavirus Infections - virology
Population studies
Registries
RESEARCH ARTICLE
Risk assessment
Risk Assessment - methods
Risk factors
Risk groups
Sampling
Sweden - epidemiology
Uterine Cervical Dysplasia - diagnosis
Uterine Cervical Dysplasia - epidemiology
Uterine Cervical Dysplasia - virology
Uterine Cervical Neoplasms - diagnosis
Uterine Cervical Neoplasms - epidemiology
Uterine Cervical Neoplasms - virology
Vaginal Smears - methods
Women
title Nationwide registry-based trial of risk-stratified cervical screening
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T07%3A40%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nationwide%20registry-based%20trial%20of%20risk-stratified%20cervical%20screening&rft.jtitle=International%20journal%20of%20cancer&rft.au=Arroyo%20M%C3%BChr,%20Laila%20Sara&rft.date=2025-01-15&rft.volume=156&rft.issue=2&rft.spage=379&rft.epage=388&rft.pages=379-388&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.35142&rft_dat=%3Cproquest_swepu%3E3093593267%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3130633587&rft_id=info:pmid/39146489&rfr_iscdi=true